ClinicalTrials.Veeva

Menu

OCS Liver DCD Trial

TransMedics logo

TransMedics

Status

Terminated

Conditions

Liver Transplant

Treatments

Device: OCS Liver System

Study type

Interventional

Funder types

Industry

Identifiers

NCT04194437
OCS-LVR-092019

Details and patient eligibility

About

Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the condition, and assess levers from DCD donors.

Full description

To evaluate the safety and effectiveness of the OCS™ Liver to preserve, optimize the condition and assess livers from DCD donors that currently are seldom used for liver transplants due to limitations of cold static storage with extended warm ischemic time and older donors.

Enrollment

9 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Registered primary liver transplant candidate
  • Age ≥ 18 years
  • Obtained informed consent

Exclusion criteria

  • Acute, fulminant liver failure
  • Prior solid organ or bone marrow transplant
  • Ventilator dependent on day of transplant/donor organ offer

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

9 participants in 1 patient group

OCS Preserved Livers
Experimental group
Description:
This is a single-arm trial of OCS preserved livers used for transplantation.
Treatment:
Device: OCS Liver System

Trial documents
1

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems